Antihyperglycemic effects of baicalin on streptozotocin - Nicotinamide induced diabetic rats

Phytotherapy Research

Volumn 25, Issue 2, 2011, Pages 189-194

  Li, Huan Ting ^a,c   Wu, Xiao Dong ^a   Davey, Andrew K ^b   Wang, Jiping ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c BAOTOU MEDICAL COLLEGE   (China)

Author keywords

baicalin; blood glucose; diabetes; hepatic glycogen; hexokinase; TNF

Indexed keywords

ADIPONECTIN; BAICALIN; CYTOKINE; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCOGEN; HEXOKINASE; INSULIN; INTERLEUKIN 6; METFORMIN; NICOTINAMIDE; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; INSULIN BLOOD LEVEL; MALE; NONHUMAN; RAT;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FLAVONOIDS; GLYCOGEN; HEXOKINASE; HYPOGLYCEMIC AGENTS; INSULIN; INTERLEUKIN-6; LIVER; MALE; METFORMIN; NIACINAMIDE; PANCREAS; RATS; RATS, WISTAR; STREPTOZOCIN; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 79551665811     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3238     Document Type: Article

References (32)

1. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME., 1993. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39: 578-582.
2. Day C., 1998. Traditional plant treatments for diabetes mellitus: pharmaceutical foods. Br J Nutr 80: 5-6.
3. Esposito K, Nappo F, Marfella R, et al,. 2002. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106: 2067-2072.
4. Fernandez-Real JM, Pickup JC., 2008. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab 19: 10-16.
5. Gastaldelli A, Miyazaki Y, Pettiti M, et al,. 2004. Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. J Clin Endocrinol Metab 89: 3914-3921.
6. Guerre-Millo M., 2008. Adiponectin: an update. Diabetes Metab 34: 12-18.
7. Hotamisligil GS, Spiegelman BM., 1994. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43: 1271-1278.
8. Kamada H, Hamada T., 1985. Comparison of anthrone and enzymic methods for hepatic glycogen analysis. Chikusan Shikenjo Kenkyu Hokoku 43: 85-92.
9. Kinney LaPier TL, Rodnick KJ., 2001. Effects of aerobic exercise on energy metabolism in the hypertensive rat heart. Phys Ther 81: 1006-1017.
10. Kwon YI, Apostolidis E, Shetty K., 2008. In vitro studies of eggplant (Solanum melongena) phenolics as inhibitors of key enzymes relevant for type 2 diabetes and hypertension. Bioresour Technol 99: 2981-2988.
11. Laakso M, Malkki M, Deeb SS., 1995. Amino acid substitutions in hexokinase II among patients with NIDDM. Diabetes 44: 330-334.
12. Liu L-L, Gong L-K, Wang H, et al,. 2008. Baicalin inhibits macrophage activation by lipopolysaccharide and protects mice from endotoxin shock. Biochem Pharmacol 75: 914-922.
13. Lu J, Wu X-D,. 2005. The therapeutic effect of baicalin on aleudrin induced rat myocardial ischemia. Chin J Clin Pharmacol Ther 10: 992-995.
14. Masiello P, Broca C, Gross R, et al,. 1998. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47: 224-229.
15. McCreanor GM, Bender DA., 1986. The metabolism of high intakes of tryptophan, nicotinamide and nicotinic acid in the rat. Br J Nutr 56: 577-586.
16. Nilsson-Ohman J, Fredrikson GN, Nilsson-Berglund LM, et al,. 2009. Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice. Arterioscler Thromb Vasc Biol 29: 1465-1470.
17. Ohkuwa T, Sato Y, Naoi M., 1995. Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci 56: 1789-1798.
18. Pociot F, Reimers JI, Andersen HU., 1993. Nicotinamide-biological actions and therapeutic potential in diabetes prevention. IDIG Workshop, Copenhagen, Denmark, 4-5 December 1992. Diabetologia 36: 574-576.
19. Rajasekaran S, Sivagnanam K, Subramanian S., 2005. Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep 57: 90-96. (Pubitemid 40601546)
20. Roytblat L, Rachinsky M, Fisher A, et al,. 2000. Raised interleukin-6 levels in obese patients. Obes Res 8: 673-675.
21. Sartipy P, Loskutoff DJ., 2003. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 100: 7265-7270.
22. Straczkowski M, Dzienis-Straczkowska S, Stepien A, Kowalska I, Szelachowska M, Kinalska I., 2002. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J Clin Endocrinol Metab 87: 4602-4606.
23. 2O2 as mediator for DNA fragmentation. Diabetes 40: 1141-1145.
24. Taskinen MR., 2002. Diabetic dyslipidemia. Atheroscler Suppl 3: 47-51.
25. Tsai C-C, Lin M-T, Wang J-J, Liao J-F, Huang W-T., 2006. The antipyretic effects of baicalin in lipopolysaccharide-evoked fever in rabbits. Neuropharmacology 51: 709-717.
26. Uchigata Y, Yamamoto H, Kawamura A, Okamoto H., 1982. Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J Biol Chem 257: 6084-6088.
27. Wan JY, Gong X, Zhang L, Li HZ, Zhou YF, Zhou QX., 2008. Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1. Eur J Pharmacol 587: 302-308.
28. WHO. 2007. Global Strategy on Diet, Physical Activity and Health. WHO: Geneva.
29. Yamamoto H, Uchigata Y, Okamoto H., 1981. DNA strand breaks in pancreatic islets by in vivo administration of alloxan or streptozotocin. Biochem Biophys Res Commun 103: 1014-1020. (Pubitemid 12189330)
30. Yamauchi T, Kamon J, Minokoshi Y, et al,. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295.
31. Zhang X-D, Wu X-D., 2007. The protection effect of baicalin on myocardial ischemia of the isolated rats heart. Chin J Clin Pharmacol Ther 12: 177-181.
32. Zozulinska D, Wierusz-Wysocka B., 2006. Type 2 diabetes mellitus as inflammatory disease. Diabetes Res Clin Pract 74: S12-S16.